Coldstream Capital Management’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-29
Closed -$383 2862
2025
Q1
$383 Buy
+29
New +$383 ﹤0.01% 3406